WP
AXSM icon

WMS Partners’s Axsome Therapeutics AXSM Stock Holding History

WMS Partners’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-40,711
Closed -$3.28M – 300
2024
Q2 		$3.28M Hold
40,711
– – 0.21% 52
2024
Q1 		$3.25M Sell
40,711
-10,000
-20% -$839K 0.22% 52
2023
Q4 		$4.04M Sell
50,711
-30,000
-37% -$2.01M 0.3% 41
2023
Q3 		$5.64M Buy
80,711
+711
+0.9% +$53.1K 0.45% 36
2023
Q2 		$5.75M Sell
80,000
-113,289
-59% -$8.36M 0.45% 37
2023
Q1 		$11.9M Hold
193,289
– – 1.04% 21
2022
Q4 		$14.9M Sell
193,289
-711
-0.4% -$42.5K 1.48% 20
2022
Q3 		$8.66M Sell
194,000
-48,500
-20% -$2.42M 1.18% 23
2022
Q2 		$9.29M Hold
242,500
– – 1.45% 14
2022
Q1 		$10M Hold
242,500
– – 1.38% 13
2021
Q4 		$9.16M Sell
242,500
-7,500
-3% -$276K 1.95% 11
2021
Q3 		$8.24M Hold
250,000
– – 1.21% 15
2021
Q2 		$16.9M Hold
250,000
– – 2.49% 8
2021
Q1 		$14.2M Hold
250,000
– – 3.22% 6
2020
Q4 		$20.4M Hold
250,000
– – 3.51% 5
2020
Q3 		$17.8M Hold
250,000
– – 3.46% 5
2020
Q2 		$20.6M Buy
+250,000
New +$19.2M 4.26% 5

Other funds holding AXSM

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WMS Partners's AXSM Position: Q3 2024 in Review

WMS Partners sold out of Axsome Therapeutics (AXSM) in Q3 2024, closing a stake of 40,711 shares — an estimated $3.28M sold.

WMS Partners first reported a position in AXSM in Q2 2020 and held it in 17 quarters. The position peaked at $20.6M in Q2 2020. 279 funds tracked by Wall St. Rank hold AXSM as of Q3 2024.

  • WMS Partners reported no remaining Axsome Therapeutics position as of Q3 2024 after selling out during the quarter.
  • WMS Partners sold 40,711 Axsome Therapeutics shares in Q3 2024, an estimated $3.28M.
  • WMS Partners first reported a position in Axsome Therapeutics in Q2 2020 and held it in 17 quarters.
  • WMS Partners's Axsome Therapeutics position peaked at $20.6M in Q2 2020.
  • 279 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2024.

Based on WMS Partners's 13F filing for Q3 2024, filed 13 Nov 2024.